MARYLAND CAPITAL ADVISORS INC.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1891201 CHESTER, MD

Position in NBIX

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$168

New position

Shares Held

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#765

of 768 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MARYLAND CAPITAL ADVISORS INC. holds $769 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (21.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	14	$222
2	NBIX	Neurocrine Biosciences Inc This page	1	$168
3	ELAN	Elanco Animal Health Inc	5	$123
4	ALKS	Alkermes plc.	2	$104
5	ZTS	Zoetis Inc.	1	$71
6	PBH	Prestige Consumer Healthcare Inc.	1	$47
7	AMRX	Amneal Pharmaceuticals, Inc.	2	$34

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$168	1	—	Shares	Defined	2026-07-17
No filing history on record for this holder in this stock.